Diarrhea was the most frequent adverse event seen in trial of<unk>  in gallstone dissolution, occurring in 2 to 9%, which is less frequent than with chenodeoxycholic acid therapy. Bacterial conversion of<unk>  to chenodeoxycholic acid may be the mechanism for this side effect. Right upper quadrant abdominal pain and exacerbation of pruritus was occasionally reported in trials in patients with PBC. Additional symptoms may include bloating, weight gain, and occasionally, thinning of hair.
Ursodeoxycholic acid
Chenodeoxycholic acid
Obeticholic acid
Rifaximin
Calcifediol
Sucralfate
Omega-3 carboxylic acids
Colestyramine